AU7270794A - Succinamide derivatives, processes for their preparation and their use as gelatinase and collagenase inhibitors - Google Patents

Succinamide derivatives, processes for their preparation and their use as gelatinase and collagenase inhibitors

Info

Publication number
AU7270794A
AU7270794A AU72707/94A AU7270794A AU7270794A AU 7270794 A AU7270794 A AU 7270794A AU 72707/94 A AU72707/94 A AU 72707/94A AU 7270794 A AU7270794 A AU 7270794A AU 7270794 A AU7270794 A AU 7270794A
Authority
AU
Australia
Prior art keywords
gelatinase
processes
preparation
collagenase inhibitors
succinamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU72707/94A
Other languages
English (en)
Inventor
Nigel Robert Arnold Beeley
Thomas Andrew Millican
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB Celltech Ltd
Original Assignee
Celltech R&D Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939315965A external-priority patent/GB9315965D0/en
Priority claimed from GB9400377A external-priority patent/GB9400377D0/en
Application filed by Celltech R&D Ltd filed Critical Celltech R&D Ltd
Publication of AU7270794A publication Critical patent/AU7270794A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU72707/94A 1993-08-02 1994-08-02 Succinamide derivatives, processes for their preparation and their use as gelatinase and collagenase inhibitors Abandoned AU7270794A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB939315965A GB9315965D0 (en) 1993-08-02 1993-08-02 Peptidyl derivatives
GB9315965 1993-08-02
GB9400377 1994-01-11
GB9400377A GB9400377D0 (en) 1994-01-11 1994-01-11 Peptidyl derivatives
PCT/GB1994/001697 WO1995004033A1 (en) 1993-08-02 1994-08-02 Succinamide derivatives, processes for their preparation and their use as gelatinase and collagenase inhibitors

Publications (1)

Publication Number Publication Date
AU7270794A true AU7270794A (en) 1995-02-28

Family

ID=26303319

Family Applications (1)

Application Number Title Priority Date Filing Date
AU72707/94A Abandoned AU7270794A (en) 1993-08-02 1994-08-02 Succinamide derivatives, processes for their preparation and their use as gelatinase and collagenase inhibitors

Country Status (6)

Country Link
US (1) US5827890A (de)
EP (1) EP0712390B1 (de)
JP (1) JPH09503492A (de)
AU (1) AU7270794A (de)
DE (1) DE69415159T2 (de)
WO (1) WO1995004033A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9507799D0 (en) * 1995-04-18 1995-05-31 British Biotech Pharm Metalloproteinase inhibitors
HUP9903863A3 (en) 1995-11-23 2000-11-28 British Biotech Pharm Metalloproteinase inhibitors
TW448172B (en) * 1996-03-08 2001-08-01 Pharmacia & Upjohn Co Llc Novel hydroxamic acid derivatives useful for the treatment of diseases related to connective tissue degradation
US5830869A (en) * 1996-06-21 1998-11-03 Mitchell; Mark Allen Thiadiazole amide MMP inhibitors
US6462023B1 (en) 1996-09-10 2002-10-08 British Biotech Pharmaceuticals, Ltd. Cytostatic agents
GB2324528B (en) * 1996-09-10 2000-07-26 British Biotech Pharm Cytostatic hydroxamic acid derivatives
US5840974A (en) * 1996-12-04 1998-11-24 Britisch Biotech Pharmaceuticals, Ltd. Metalloproteinase inhibitors
US5847148A (en) * 1997-04-10 1998-12-08 Pharmacia & Upjohn Company Thiadiazole derivatives useful for the treatment of diseases related to connective tissue degradation
GB9803005D0 (en) * 1998-02-12 1998-04-08 British Biotech Pharm Anti-inflammatory agents
GB9804777D0 (en) * 1998-03-07 1998-04-29 British Biotech Pharm Anti-inflammatory agents
US6329418B1 (en) 1998-04-14 2001-12-11 The Procter & Gamble Company Substituted pyrrolidine hydroxamate metalloprotease inhibitors
US6696456B1 (en) 1999-10-14 2004-02-24 The Procter & Gamble Company Beta disubstituted metalloprotease inhibitors
RU2245876C2 (ru) * 2000-03-21 2005-02-10 Дзе Проктер Энд Гэмбл Компани Производные сульфонамидов и фармацевтическая композиция на их основе
AU2001245862A1 (en) * 2000-03-21 2001-10-03 The Procter & Gamble Company Difluorobutyric acid metalloprotease inhibitors
CA2403778A1 (en) * 2000-03-21 2001-09-27 The Procter & Gamble Company Carbocyclic side chain containing metalloprotease inhibitors
WO2002006227A1 (fr) * 2000-07-18 2002-01-24 Chugai Seiyaku Kabushiki Kaisha Inhibiteurs de la metalloprotease matricielle
US6452041B1 (en) 2000-10-16 2002-09-17 Pfizer Inc. Olefination process to itaconate and succinate derivatives
GB0025310D0 (en) * 2000-10-16 2000-11-29 Pfizer Ltd Process
US20080279936A1 (en) * 2001-10-10 2008-11-13 The University Of Pittsburgh Estradiol metabolites for reduction of endothelin production

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2073513A1 (en) * 1990-12-03 1992-06-04 John Robert Porter Peptidyl derivatives
CA2058797A1 (en) * 1991-02-01 1992-08-02 Michael John Broadhurst Amino acid derivatives

Also Published As

Publication number Publication date
DE69415159D1 (de) 1999-01-21
EP0712390B1 (de) 1998-12-09
JPH09503492A (ja) 1997-04-08
EP0712390A1 (de) 1996-05-22
DE69415159T2 (de) 1999-07-22
WO1995004033A1 (en) 1995-02-09
US5827890A (en) 1998-10-27

Similar Documents

Publication Publication Date Title
AU7270794A (en) Succinamide derivatives, processes for their preparation and their use as gelatinase and collagenase inhibitors
AU5533094A (en) Enzyme inhibitors
AU6718494A (en) 2-substituted-3,4-diarylthiophene derivatives as inhibitors of cyclooxygenase
AU4251993A (en) Substituted 4-aza-5A-androstan-ones as 5A-reductase inhibitors
AU6961894A (en) Diamondoid derivatives for pharmaceutical use
IL138028A0 (en) Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical use
AU6510294A (en) Hydroxamic acid derivatives
AU1301697A (en) Tyrosin-derivate as alpha-v-integrin inhibitors
AU3986795A (en) Succinic acid derivatives and their use as surfactants
AU7705694A (en) Substituted urea and isothiourea derivatives as no synthase inhibitors
HUP9800634A3 (en) P-amidino-benzylamide derivatives as thrombin inhibitors, intermediates and use thereof
AU7294098A (en) Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
AU9122391A (en) Hiv protease inhibitors
AU6135294A (en) Piperazine derivatives as hiv protease inhibitors
AU6183794A (en) Guanidinyl- or amidinyl-substituted methylamino heterocyclic thrombin inhibitors
AU3107795A (en) Inhibitors of the benzamidine type
AU5182593A (en) N,N-disubstituted arylcycloalkylamines
AU7963394A (en) Mercaptosulfide metalloproteinase inhibitors
AU1282795A (en) Prostaglandin derivative, salt thereof, and use thereof
ZA949148B (en) 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents
AU3901393A (en) Biphenylylquinuclidine derivatives as squalene synthase inhibitors
AU6983494A (en) Indazolesulfonylurea derivative, use thereof, and intermediate for production thereof
AU6946491A (en) Orally active renin inhibitors
AU6282494A (en) 4-aminopyridines, their production and use as an antithrombosis agent
AU1766997A (en) Beta-thiopropionyl-aminoacid derivatives and their use as beta-lactamase inhibitors